MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹273 Cr | ₹205 Cr | ₹84 Cr | ₹57 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹84 Cr |
| Mar2022 | ₹57 Cr |
| Mar2021 | ₹24 Cr |
How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | 33.00 | |
| Mar2024 | ₹205 Cr | 143.34 | |
| Mar2023 | ₹84 Cr | 47.80 | |
| Mar2022 | ₹57 Cr | 140.72 | |
| Mar2021 | ₹24 Cr | - | |
Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,314.1 Cr | 7.2% | 25.7% | -4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 7.2% |
25.7% |
-4.2% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses